Targeting colony stimulating factor-1 receptor signalling to treat ectopic pregnancy

1–2% of pregnancies are ectopic, the majority implanting in the Fallopian tube. A single, systemic dose of methotrexate, a DNA-synthesis (S phase) inhibitor, has been used since 1991 for outpatient treatment of women with stable EP. However, methotrexate has limited clinical and cost effectiveness,...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmad, S. Furquan, Duncan, W. Colin, Campbell, Lisa L., Beaty, Robyn E., Koscielniak, Magda, Collins, Frances, Saunders, Philippa T. K., Horne, Andrew W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519033/
https://www.ncbi.nlm.nih.gov/pubmed/32973322
http://dx.doi.org/10.1038/s41598-020-72785-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519033/
https://www.ncbi.nlm.nih.gov/pubmed/32973322
http://dx.doi.org/10.1038/s41598-020-72785-y

Ejemplares similares